Ziftomenib FDA approval date

The FDA approved Ziftomenib (KO-539) on 13 Nov 2025.

FDA approval date
13 Nov 2025

Drug identity checked against registry records

Also recorded as KO-539

Included trials

TrialSponsorPhaseStatusPrimary completion
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLNCT07007312KURAPhase 3Recruiting2031-11Estimated

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2025-11-13DayZiftomenibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220305", "applicant_as_listed_by_fda": "KURA", "brand_names": ["KOMZIFTI"], "active_ingredients": ["ZIFTOMENIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20251113", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026